PI
Pharmstandard International Portfolio holdings
AUM $29M
1-Year Return
2.12%
This Quarter Return
+31.26%
1 Year Return
+2.12%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$33.4M
AUM Growth
+$6.4M
(+24%)
Cap. Flow
+$1.01M
Cap. Flow
% of AUM
3.01%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
Protara Therapeutics
TARA
|
+$1.01M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Protagonist Therapeutics
PTGX
$3.63B
| $17.4M | 50.6% |
982,270
| – | – |
|
|
JNCE
2
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $10.3M | 30.07% |
662,063
| – | – |
|
|
3
Protara Therapeutics
TARA
$122M
| $3.34M | 9.72% |
41,698
+12,564
| +43% | +$1.01M |
|
|
ARGS
4
DELISTED
Argos Therapeutics, Inc.
ARGS
| $2.38M | 6.93% |
662,114
| – | – |
|